drugset / Trial / NCT01364428
Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to compare the efficacy and safety of two different formulations of insulin degludec (IDeg) in subjects with type 2 diabetes.
Timeline
- Start
- 2011-06
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin degludec | Protein / enzyme biologic | — | Subcutaneous |